Stem Cell Aggregates for Retinal Tissue Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating stem cells into retinal tissue are inefficient, with conventional methods failing to produce a clear morphology of cortical tissue and low induction efficiency for diencephalon tissue, and struggling to selectively differentiate into specific retinal neurons.
Innovation Solution
A method involving the formation of homogenous stem cell aggregates in a serum-free medium followed by suspension culture in the presence of a basement membrane reference standard, such as laminin, type IV collagen, heparan sulfate proteoglycan, and entactin, with the addition of KSR, Nodal, or Activin, to induce the formation of optic cup-like structures and retinal tissue with a functional laminar structure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional differentiation methods are used for stem cells, then general nerve cells can be produced, but selective differentiation into specific retinal neurons cannot be achieved
Solution Approach 1:
The patent applies local quality by providing differentiating factors at specific concentrations and timings during culture. Different retinal neuron types are induced by controlling the local concentration and temporal sequence of growth factors in the culture medium, enabling selective differentiation into specific retinal cell types rather than general nerve cells.
Solution Approach 2:
The patent employs preliminary action by first forming homogenous stem cell aggregates in suspension culture before initiating differentiation. This preliminary aggregation step creates a three-dimensional structure that mimics early retinal development, preparing the cells for subsequent selective differentiation into organized retinal tissue with specific neuronal subtypes.
2Productivity
If stem cells are cultured to produce large quantities of nerve cells, then cell availability increases, but tissue organization and laminar structure are lost
Solution Approach 1:
The patent transitions from two-dimensional monolayer culture to three-dimensional suspension aggregate culture. This dimensional change allows cells to self-organize into spheroidal aggregates that mimic the three-dimensional architecture of developing retinal tissue, preserving laminar structure while enabling scalable production through suspension culture conditions.
Solution Approach 2:
The patent employs self-service by allowing stem cells to spontaneously self-organize into aggregated structures with intrinsic laminar organization when cultured in suspension. The cells autonomously form three-dimensional aggregates with differentiated regions that replicate natural retinal tissue architecture without requiring external structural guidance or complex culture apparatus.
3Productivity
If animal-derived induction factors are used, then differentiation efficiency improves, but safety risks for transplantation increase
Solution Approach 1:
The patent replaces expensive, complex animal-derived growth factors with simplified, defined chemical compounds that can be precisely controlled and are free from animal contaminants. This substitution maintains differentiation efficiency while eliminating immunogenicity risks and pathogen transmission concerns associated with animal-derived products, making the process suitable for clinical transplantation.
Data Source
AI summary
Provided is a method of inducing the differentiation of a stem cell into nerve progenitor cells, comprising the step (1) of forming homogenous aggregates of stem cells in a serum-free medium (1) and the step (2) of suspension-culturing the homogenous aggregates of stem cells in the presence of a basement membrane reference standard.